PUBLISHED DATE : Dec 2020 | Pages : 227
Fill out your details & get your free sample
Benign Prostatic Hyperplasia (BPH) Devices Market Size, Share, Trends, Analysis Report by Procedure (Prostatic Urethral Lift (PUL), Laser Therapy, Transurethral Resection of the Prostate (TURP) and Others), End-users (Hospitals, Specialty Urology Centers, and Ambulatory Surgery Centers (ASC)) and Geography (APAC, Europe, North America, Latin America, and Middle East & Africa) Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Landscape, Market Share & Forecast, 2020–2025
227 Pages
114 Tables
63 Charts
5 Regions
16 Countries
19 Companies
3 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (Revenue) | USD 800 Million (2020) |
| CAGR | 22% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020-2025 |
| Market Segments | Procedure (Prostatic Urethral Lift (PUL), Laser Therapy, Transurethral Resection of the Prostate (TURP) and Others), End-users (Hospitals, Specialty Urology Centers, and Ambulatory Surgery Centers (ASC)) |
| Geographic Analysis | APAC, Europe, North America, Latin America, and Middle East & Africa |
| Countries Covered | Spain, Germany, Italy, France, UK, US, Canada, South Korea, China, Japan, Australia, India, Brazil, Mexico, Turkey, and South Africa |
The global benign prostatic hyperplasia (BPH) devices market size to cross USD 800 million by 2020, growing at a CAGR of over 22% during the forecast period. The BPH devices market is expected to observe an absolute growth of over 242% during the forecast period. The growing number of elderly men population is a primary factor responsible for influencing the BPH devices market growth.
Benign prostatic hyperplasia is one of the most common diseases in men, which generally develops after the age of 40 years, with a prevalence rate of around 8–60% between 40 and 90 years. Moreover, it affects about 70% of US men between the age of 60 and 69 years. Approximately 32 million men worldwide experience mild to severe symptoms of BPH. According to several medical studies, there are more than 50% of men above age 50 diagnosed with an enlarged prostate. Besides, there are 4 million men who suffer from benign prostatic hyperplasia. Hence, the high prevalence among men is a major factor contributing to the demand for advanced medical devices.
Another factor that is expected to drive the market is the emergence of advanced and innovative BPH therapies to provide quality care to patients in outpatient centers in less time and at an affordable cost. Although medication is the first line of treatment preferred by several patients, around 45 to 60% of patients tend to opt for advanced therapies to get relief from lower urinary tract symptoms (LUTS) and other complications immediately. Hence, the emergence of innovative BPH treatment devices is expected to reduce complications associated with traditional BPH treatment, thereby driving the demand for advanced devices.
This research report includes a detailed segmentation by
The PUL technology segment is growing due to the increasing patient population and the growing adoption of advanced minimally invasive treatment. PUL is an advanced minimally invasive procedure for the treatment of BPH with less complications. As these procedures can be performed under local, spinal, or general anesthesia or in in-office settings or clinics, the technique is grabbing attention among end-users in developed economies, thereby influencing the segment.
The medical laser market is growing at a significant rate due to the increasing awareness of BPH, and several treatment options using advanced medical devices. As there is a rise in the number of the patient population, the demand for laser therapies is likely to grow. Also, an accelerated demand for medical lasers is observed to treat multiple diseases, this is increasing the demand for non-invasive treatment devices among end-users, thereby driving the growth in the benign prostatic hyperplasia devices market.
Transurethral resection procedures (TURP) have been a standard medical procedure for the treatment of BPH in the last more than 60 years. It has been the most suitable treatment for lower urinary tract obstructions caused by BPH. The increase in the elderly population is one of the major factors driving the demand for TURP. The adoption of these procedures is high in hospitals, where there is a scarcity of well-developed innovative devices. However, the availability of advanced treatment options is decreasing the adoption of traditional resectoscope treatment options, thereby influencing the growth during the forecast period.
In 2019, the hospital end-user was the largest segment in the global benign prostatic hyperplasia devices market. However, the segment is likely to witness the slowest growth during the forecast period due to the change in patients’ preference in terms of treatment. As BPH surgical treatment is witnessing the application of innovative MI devices, BPH surgical care is moving toward out-patient settings. However, the increasing aging population and the growing patient group with BPH have led to high hospitalization rates. Most patients prefer hospitals, especially public ones, as their priority due to the availability of insurance coverage and less out-of-pocket expenses in case of inadequate reimbursement for BPH surgeries. Further, the availability of skilled healthcare professionals with knowledge and expertise in performing both invasive and MI BPH surgeries also attracts more patients to hospitals.
Specialty urology clinics are expected to grow at a phenomenal rate due to the increased acceptance of several in-office based BPH therapies, especially in North America, Europe, and APAC. In-office therapies are non-surgical procedures performed in the urologist’s clinics in less than one hour. With several research studies confirming minimally Invasive options as safe, effective, and durable for treating BPH, the specialist clinic segment is likely to grow during the forecast period.
The introduction of ASCs has lowered the rate of out-patient urologic surgeries performed in expensive hospital settings. The volume of outpatient surgeries has increased dramatically over the past three decades due to advances in medical technology and payment incentives. ASCs have several advantages, most of which are derived from their operational efficiency. For payers, ASCs provide similar care at a low cost per episode. ASCs offer a patient-centered experience in a comfortable environment with lower co-payments.
North America is growing at a fast CAGR due to the growing preference for technologically advanced BPH devices. Although the high cost of BPH devices can affect the market adversely, the presence of reimbursement coverage for both invasive and minimally invasive treatment options will have a positive impact on the growth. The availability of reimbursement coverage for several BPH devices is likely to boost the market in the region. North America is currently dominating the TURP segment, with around 150,000 people in the US opting for TURPs annually because of high medical reimbursement facilities. Therefore, the market is growing at significant growth, and the region is dominating the market and expected to dominate in the upcoming years.
Germany, the UK, France, Spain, and Italy are the major revenue contributors in Europe. The benign prostatic hyperplasia devices market is growing at a healthier rate in the APAC, Latin America, and the Middle East & Africa due to the presence of sophisticated healthcare infrastructure. The prevalence of BPH is more than 10.3% in recent years, and the trend is likely to grow due to the increasing elderly population, especially men. According to a survey, around 29% of European men aged between 50 and 80 years have moderate to severe LUTS. As Europe has high availability of skilled professionals and the healthcare infrastructure is well developed for the use of BPH advanced technology such as minimally invasive surgery devices and lasers, the adoption is likely to boost in the region.
Japan is the major revenue contributor to the APAC BPH devices market due to the increasing prevalence and high adoption of TURP and laser therapies for the treatment of patients. China is the second major revenue contributor to the APAC region due to the presence of a large pool of patients that use technologically advanced devices. The demand for TURP is relatively higher in the region than other procedures as this method is clinically proven and widely accepted treatment option for BPH. Laser therapy is also gaining traction in countries such as Japan, Australia, South Korea, China, and India.
The global BPH devices market is fairly concentrated and is characterized by the presence of established vendors holding the majority of the share. There is a significant number of global as well as regional players offering advanced BPH devices in the market. Teleflex, KARL STORZ SE & Co. KG, Lumenis, Urologix, and Boston Scientific are the major players operating in the benign prostatic hyperplasia devices market. These companies have a wide geographic footprint, diversified product portfolio, and a strong focus on innovation and research activities.
Segmentation by Procedure
By End-user
By Geography
Frequently Asked Questions
What is the market size and CAGR of the global benign prostatic hyperplasia (BPH) devices market?
The benign prostatic hyperplasia (BPH) devices market size to reach revenues of over $800 million by 2020, growing at a CAGR of around 22% by 2025.
Japan is the major revenue contributor to the APAC BPH devices market due to the increasing prevalence and high adoption of TURP and laser therapies for the treatment of patients.
What are the drivers, trends, and restraints impacting the laser therapy market?
The laser segment is growing at a significant rate due to the increasing awareness of BPH, and several treatment options using advanced medical devices.
Who are the top vendors of the BPH devices market and what are their market shares?
The key vendors in the benign prostatic hyperplasia (BPH) devices market are KARL STORZ, Lumenis, Boston Scientific, Urologix, and Teleflex. The established players hold majority of the market share.
Which region/end-user is the largest revenue generating segment in the BPH devices market?
In 2019, the hospital end-user was the largest segment in the global benign prostatic hyperplasia devices market.
The global benign prostatic hyperplasia devices market is expected to grow at a CAGR of over 22% during the period 2019–2025.
The following factors are likely to contribute to the growth of the benign prostatic hyperplasia devices market during the forecast period:
Base Year: 2019
Forecast Year: 2020–2025
The study considers the present scenario of the benign prostatic hyperplasia devices market and its market dynamics for the period 2019−2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The study offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent companies operating in the market.
Key Vendors
Other Vendors
Market Segmentation by Procedure
Market Segmentation by End-user
Market Segmentation by Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments
4.4.1 Market Segmentation by Procedure
4.4.2 Market Segmentation by End-User
4.4.3 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.1.1 Innovations in BPH Treatment
8 Market Opportunities & Trends
8.1 Emergence Of Innovative BPH Treatment Devices
8.2 Increasing Demand For In-Office BPH Treatment
8.3 Popularity Of Robotic-Assistance Surgical Techniques
9 Market Growth Enablers
9.1 Increasing Patient Population
9.2 Growing Demand For Minimally Invasive Treatment
9.3 Technological Advances
10 Market Restraints
10.1 Higher Adoption Of Medications
10.2 High Cost Of BPH Devices & Surgeries
10.3 Complications Associated With BPH Devices
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Procedure
11.2.2 End-users
11.2.3 Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Procedure
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Prostatic Urethral Lift (PUL)
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Market by Geography
12.4 Laser
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Market by Geography
12.5 Transurethral Resection Of The Prostate (TURP)
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 Market by Geography
12.6 Others
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.6.3 Market by Geography
13 End-User
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Hospitals
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Specialty Urology Clinics
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 ASCs
13.5.1 Market Overview
13.5.2 Market Size & Forecast
14 Geography
14.1 Market Snapshot & Growth Engine
14.2 Geographic Overview
15 North America
15.1 Market Overview
15.2 Market Size & Forecast
15.3 North America: Procedure Segmentation
15.3.1 Market Snapshot & Growth Engine
15.4 Key Countries
15.4.1 US: Market Size & Forecast
15.4.2 Canada: Market Size & Forecast
16 Europe
16.1 Market Overview
16.2 Market Size & Forecast
16.3 Procedure Segmentation
16.3.1 Market Snapshot & Growth Engine
16.4 Key Countries
16.4.1 Germany: Market Size & Forecast
16.4.2 UK: Market Size & Forecast
16.4.3 France: Market Size & Forecast
16.4.4 Spain: Market Size & Forecast
16.4.5 Italy: Market Size & Forecast
17 APAC
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Procedure Segmentation
17.3.1 Market Snapshot & Growth Engine
17.4 Key Countries
17.4.1 Japan: Market Size & Forecast
17.4.2 China: Market Size & Forecast
17.4.3 Australia: Market Size & Forecast
17.4.4 South Korea: Market Size & Forecast
17.4.5 India: Market Size & Forecast
18 Latin America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Procedure Segmentation
18.3.1 Market Snapshot & Growth Engine
18.3.2 Market Size & Forecast
18.4 Key Countries
18.4.1 Brazil: Market Size & Forecast
18.4.2 Mexico: Market Size & Forecast
19 Middle-East & Africa
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Procedure Segmentation
19.3.1 Market Snapshot & Growth Engine
19.4 Key Countries
19.4.1 Turkey: Market Size & Forecast
19.4.2 Saudi Arabia: Market Size & Forecast
20 Competitive Landscape
20.1 Competition Overview
20.2 Market Share Analysis
20.2.1 Teleflex
20.2.2 Karl Storz
20.2.3 Lumenis
20.2.4 Boston Scientific
20.2.5 Urologix
21 Key Company Profiles
21.1 Karl Storz
21.1.1 Business Overview
21.1.2 Product Offerings
21.1.3 Key Strategies
21.1.4 Key Strengths
21.1.5 Key Opportunities
21.2 Lumenis
21.2.1 Business Overview
21.2.2 Product Offerings
21.2.3 Key Strategies
21.2.4 Key Strengths
21.2.5 Key Opportunities
21.3 Boston Scientific
21.3.1 Business Overview
21.3.2 Product Offerings
21.3.3 Key Strategies
21.3.4 Key Strengths
21.3.5 Key Opportunities
21.4 Urologix
21.4.1 Business Overview
21.4.2 Product Offerings
21.4.3 Key Strategies
21.4.4 Key Strengths
21.4.5 Key Opportunities
21.5 Teleflex
21.5.1 Business Overview
21.5.2 Product Offerings
21.5.3 Key Strategies
21.5.4 Key Strengths
21.5.5 Key Opportunities
22 Other Prominent Vendors
22.1 BD
22.1.1 Business Overview
22.1.2 Product Offerings
22.2 Olympus
22.2.1 Business Overview
22.2.2 Product Offerings
22.3 Richard Wolf
22.3.1 Business Overview
22.3.2 Product Offerings
22.4 OmniGuide
22.4.1 Business Overview
22.4.2 Product Offerings
22.5 Urotech Devices
22.5.1 Business Overview
22.5.2 Product Offerings
22.6 biolitec
22.6.1 Business Overview
22.6.2 Product Offerings
22.7 PROCEPT BioRobotics
22.7.1 Business Overview
22.7.2 Product Offerings
22.8 Medi-Tate
22.8.1 Business Overview
22.8.2 Product Offerings
22.9 Pnn Medical
22.9.1 Business Overview
22.9.2 Product Offerings
22.10 MEDpro Medical
22.10.1 Business Overview
22.10.2 Product Offerings
22.11 Allium Medical
22.11.1 Business Overview
22.11.2 Product Offerings
22.12 SRS Medical
22.12.1 Business Overview
22.12.2 Product Offerings
22.13 Rocamed
22.13.1 Business Overview
22.13.2 Product Offerings
22.14 Coloplast
22.14.1 Business Overview
22.14.2 Product Offerings
23 Report Summary
23.1 Key Takeaways
23.2 Strategic Recommendations
24 Quantitative Summary
24.1 Market By Procedure
24.2 Market By End-User
24.3 Market By Geography
25 Appendix
25.1 Abbreviations
List Of Exhibits
Exhibit 1 Global BPH Devices Market: Segmentation
Exhibit 2 Market Size Calculation Approach 2019
Exhibit 3 Average Prostate Gland Weight by Age Group
Exhibit 4 Symptoms of BPH
Exhibit 5 Impact of Emergence of Innovative BPH Treatment Devices
Exhibit 6 Impact of Increasing Demand for In-Office BPH Treatment
Exhibit 7 Benefits of In-office BPH Treatment
Exhibit 8 Impact of Popularity of Robotic-Assistance Surgical Techniques
Exhibit 9 AquaBeam Robotic System, an Advanced Robotic Surgery Treatment Offers Various Advantages Such as:
Exhibit 10 Impact of Increasing Patient Population
Exhibit 11 Prevalence Rate of BPH According to Age Group in 2017
Exhibit 12 Broad Categories of Epidemiologic Risk Factors for BPH
Exhibit 13 Impact of Growing Demand for Minimally Invasive Treatment
Exhibit 14 Criteria for Deciding Right Type of MI Surgical Technique for BPH
Exhibit 15 Major Minimally Invasive Treatment Options for BPH
Exhibit 16 Impact of Technological Advances
Exhibit 17 Impact of Higher Adoption of Medications
Exhibit 18 Different Treatment Options for BPH & Adoption (%)
Exhibit 19 Impact of High Cost of BPH Devices & Surgeries
Exhibit 20 Impact of Complications Associated with BPH Devices
Exhibit 21 Complications of Minimally Invasive Treatments
Exhibit 22 Comparison of BPH Treatment Complications
Exhibit 23 Total Readmission for Different Procedures (%)
Exhibit 24 Global BPH Devices Market 2019–2025 ($ million)
Exhibit 25 Global BPH Devices Market by Procedure
Exhibit 26 Global BPH Devices Market by End-users
Exhibit 27 Global BPH Devices Market by Geography
Exhibit 28 Five Forces Analysis 2019
Exhibit 29 Incremental Growth by Procedure 2019 & 2025
Exhibit 30 Global BPH Devices Market by Procedure
Exhibit 31 Global BPH Devices Market by Procedure: Incremental Value ($ million)
Exhibit 32 Global BPH Devices Market by Procedure: Absolute Growth (%)
Exhibit 33 Global BPH Devices Market by Procedure 2019 & 2025 (%)
Exhibit 34 PUL Market: Absolute & Incremental Growth
Exhibit 35 Advantages of PUL
Exhibit 36 Global BPH Devices Market 2019–2025 ($ million)
Exhibit 37 Laser Market: Absolute & Incremental Growth
Exhibit 38 Advantages of Laser Therapy
Exhibit 39 Global Laser Market 2019–2025 ($ million)
Exhibit 40 Global TURP Market 2019–2025 ($ million)
Exhibit 41 Global Other Procedures Market: Absolute & Incremental Growth
Exhibit 42 Benefits of MI Treatments
Exhibit 43 Global BPH Devices Market 2019–2025 ($ million)
Exhibit 44 Incremental Growth by End-user 2019 & 2025
Exhibit 45 Global BPH Devices Market by End-User
Exhibit 46 Global BPH Devices Market by End-users: Incremental Value ($ million)
Exhibit 47 Global BPH Devices Market by End-Users: Absolute Growth (% share)
Exhibit 48 Global BPH Devices Market by End-Users 2019 & 2025 (% share)
Exhibit 49 Global BPH Devices Market by End-user 2019−2025 ($ million)
Exhibit 50 Global BPH Devices Market by End-user 2019−2025 (%)
Exhibit 51 Global BPH Devices Market by Hospitals: Incremental & Absolute Growth Comparison
Exhibit 52 Global BPH Devices Market by Hospitals 2019–2025 ($ million)
Exhibit 53 Global BPH Devices Market by Specialty Urology Clinics: Incremental & Absolute Growth
Exhibit 54 Advantages of In-office BPH Treatment Options
Exhibit 55 Global BPH Devices Market by Specialty Urology Clinics Market 2019–2025 ($ million)
Exhibit 56 Global ASCs Market by Hospital End-user: Incremental & Absolute Growth
Exhibit 57 Global BPH Devices Market by ASCs 2019–2025 ($ million)
Exhibit 58 Incremental Growth by Geography 2019 & 2025
Exhibit 59 Global BPH Devices Market by Geography
Exhibit 60 Global BPH Devices Market by Geography: Incremental Value ($ million)
Exhibit 61 Global BPH Devices Market by Geography: Absolute Growth (%)
Exhibit 62 Global BPH Devices Market by Geography 2019 & 2025 (%)
Exhibit 63 Global BPH Devices Market in North America 2019
Exhibit 64 North America BPH Devices Market: Absolute & Incremental Growth
Exhibit 65 BPH Devices Market in North America 2019–2025 ($ million)
Exhibit 66 North America BPH Devices Market Incremental Growth by Procedure 2019 & 2025
Exhibit 67 BPH Devices Market Incremental Growth in North America 2019 & 2025
Exhibit 68 BPH Devices Market in the US 2019–2025 ($ million)
Exhibit 69 BPH devices Market in Canada 2019–2025 ($ million)
Exhibit 70 BPH Device Market in Europe: Key Countries 2019 ($ million)
Exhibit 71 Europe BPH Devices Market 2019: Increment & Absolute Growth Comparison
Exhibit 72 BPH Devices Market in Europe 2019–2025 ($ million)
Exhibit 73 Europe BPH Devices Market Incremental Growth by Procedure 2019 & 2025
Exhibit 74 BPH Devices Market Incremental Growth in Europe 2019 & 2025
Exhibit 75 BPH Devices Market in Germany 2019–2025 ($ million)
Exhibit 76 BPH Devices Market in UK 2019–2025 ($ million)
Exhibit 77 BPH Devices Market in France 2019–2025 ($ million)
Exhibit 78 BPH Devices Market in Spain 2019–2025 ($ million)
Exhibit 79 BPH Devices Market in Italy 2019–2025 ($ million)
Exhibit 80 APAC BPH Devices Market: Key Countries 2019 ($ million)
Exhibit 81 APAC BPH Devices Market 2019: Increment & Absolute Growth
Exhibit 82 Individuals Aware of BPH Devices and Treatment (% of respondent)
Exhibit 83 BPH Devices Market in APAC 2019–2025 ($ million)
Exhibit 84 APAC BPH Devices Market Incremental Growth by Procedure 2019 & 2025
Exhibit 85 BPH Devices Market Incremental Growth in APAC 2019 & 2025
Exhibit 86 BPH Devices Market in Japan 2019–2025 ($ million)
Exhibit 87 Prevalence of BPH in China by Age Group
Exhibit 88 BPH Devices Market in China 2019–2025 ($ million)
Exhibit 89 BPH Devices Market in Australia 2019–2025 ($ million)
Exhibit 90 BPH Devices Market in South Korea 2019–2025 ($ million)
Exhibit 91 BPH Devices Market in India 2019–2025 ($ million)
Exhibit 92 Latin America BPH Devices Market: Key Countries 2019 ($ million)
Exhibit 93 Latin America BPH Devices Market 2019: Increment & Absolute Growth Comparison
Exhibit 94 BPH Devices Market in Latin America 2019–2025 ($ million)
Exhibit 95 Latin America BPH Devices Market Incremental Growth by Procedure 2019 & 2025
Exhibit 96 BPH Devices Market Incremental Growth in Latin America 2019 & 2025
Exhibit 97 BPH Devices Market in Brazil 2019–2025 ($ million)
Exhibit 98 BPH Devices Market in Mexico 2019–2025 ($ million)
Exhibit 99 Middle East & Africa BPH Devices Market: Key Countries 2019 ($ million)
Exhibit 100 MEA BPH Devices Market 2019: Increment & Absolute Growth Comparison
Exhibit 101 BPH Devices Market in MEA 2019–2025 ($ million)
Exhibit 102 BPH Devices Market Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 103 BPH Devices Market Incremental Growth in Middle East & Africa 2019 & 2025
Exhibit 104 BPH devices Market in Turkey 2019–2025 ($ million)
Exhibit 105 BPH Devices Market in Saudi Arabia 2019–2025 ($ million)
Exhibit 106 Teleflex’s UroLift Revenue 2018 & 2019 ($ million)
Exhibit 107 Boston Scientific Sales Revenue 2019-2017 ($million)
Exhibit 108 Boston Scientific: Revenue by Business Segment 2017−2018 ($ million)
Exhibit 109 Boston Scientific R&D Expenditure 2016-2018 ($ million)
Exhibit 110 Boston Scientific Revenue Share by Business Segments 2019 (% share)
Exhibit 111 Boston Scientific Share by Region (% share)
Exhibit 112 Urologix Key Milestones
Exhibit 113 Teleflex Revenue 2016-2018 ($ million)
Exhibit 114 Teleflex R&D Expenditure 2016-2018 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2019
Table 3 Existing and Emerging Vendors offering Innovative Investigational and Approved BPH Devices
Table 4 Vendors Offering In-Office BPH Treatment Devices
Table 5 Types of MIT and Factors Specific to Each Type
Table 6 Vendors Offering Technologically Advanced Devices
Table 7 Medication Used for BPH treatment
Table 8 Global BPH Devices Market by Procedure 2019−2025 ($ million)
Table 9 Global BPH Devices Market by Procedure 2019−2025 (%)
Table 10 Global PUL Market by Geography 2019−2025 ($ million)
Table 11 Global PUL Market by Geography 2019−2025 (% share)
Table 12 Cost Comparison of GreenLight Laser Therapy versus TURP ($)
Table 13 Vendors Offering Laser Devices for BPH Treatment
Table 14 Global Laser Market by Geography 2019−2025 ($ million)
Table 15 Global Laser Market by Geography 2019−2025 (% share)
Table 16 Vendors Offering TURP Devices
Table 17 Global TURP Market by Geography 2019−2025 ($ million)
Table 18 Global TURP Market by Geography 2019−2025 (% share)
Table 19 Vendors Offering MITs
Table 20 Global Others Market by Geography 2019−2025 ($ million)
Table 21 Global Others Market by Geography 2019−2025 (% share)
Table 22 Global BPH Devices Market by Geography 2019−2025 ($ million)
Table 23 Global BPH Devices Market by Geography 2019−2025 (%)
Table 24 North America BPH Devices Market by Procedure 2019−2025 ($ million)
Table 25 Europe BPH Devices Market by Procedure 2019−2025 ($ million)
Table 26 APAC BPH Devices Market by Procedure 2019−2025 ($ million)
Table 27 Latin America BPH Devices Market by Procedure 2019−2025 ($ million)
Table 28 Middle East & Africa BPH Devices Market by Procedure 2019−2025 ($ million)
Table 29 Global BPH Devices Vendor Ranking 2019
Table 30 KARL STORZ: Major Product Offerings
Table 31 Lumenis: Major Product Offerings
Table 32 Boston Scientific: Major Product Offerings
Table 33 Urologix: Major Product Offerings
Table 34 Teleflex: Major Product Offerings
Table 35 BD: Major Product Offerings
Table 36 Olympus: Major Product Offerings
Table 37 Richard Wolf: Major Product Offerings
Table 38 OmniGuide: Major Product Offerings
Table 39 Urotech Devices: Major Product Offerings
Table 40 Biolitec: Major Product Offerings
Table 41 PROCEPT BioRobotics: Major Product Offerings
Table 42 Medi-Tate: Major Product Offerings
Table 43 Pnn Medical: Major Product Offerings
Table 44 MEDpro Medical: Major Product Offerings
Table 45 Allium Medical: Major Product Offerings
Table 46 SRS Medical: Major Product Offerings
Table 47 ROCAMED: Major Product Offerings
Table 48 Coloplast: Major Product Offerings
Table 49 Global BPH Devices Market by Procedure 2019−2025 ($ million)
Table 50 Global BPH Devices Market by Procedure 2019−2025 (%)
Table 51 Global BPH Devices Market by End-User 2019−2025 ($ million)
Table 52 Global BPH Devices Market by End-User 2019−2025 (%)
Table 53 Global BPH Devices Market by Geography 2019−2025 ($ million)
Table 54 Global BPH Devices Market by Product 2019−2025 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
